Between October 18–21, this website will move to a new web address (from health.gov to odphp.health.gov). During that time, some functions might not work as expected. We appreciate your patience and understanding as we’re working to make this transition as smooth as possible.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Retention Strategies for Medications for Addiction Treatment in Adults With Opioid Use Disorder

About this resource:

HHS Non-systematic Review

Source: Agency for Healthcare Research and Quality

Last Reviewed: August 2020

Workgroups: Substance Use Workgroup

In this rapid evidence review, researchers looked at systematic reviews and randomized controlled trials to summarize evidence on the effectiveness of interventions involving medications for addiction treatment (MAT) in adults with opioid use disorder. They found that people who get longer-term MAT treatment have better outcomes but noted that fewer than half of the studies in their review measured treatment retention as a primary outcome. They also looked at the effectiveness of specific medicines and at the effects of combining MAT with other services.

Read more about this resource

Objectives related to this resource (2)

Increase the proportion of people with a substance use disorder who got treatment in the past year — SU‑01
Little or no detectable change
Reduce the proportion of people who had opioid use disorder in the past year — SU‑18
Improving

Suggested Citation

1.

Chan B, Gean E, Arkhipova-Jenkins I, et al. (2020) Retention Strategies for Medications for Addiction Treatment in Adults With Opioid Use Disorder: A Rapid Evidence Review. AHRQ Publication No. 20-EHC012. Retrieved from https://effectivehealthcare.ahrq.gov/products/retention-strategies-opioid-use-disorder/rapid-research